Arterial Stents
Arterial Stents

Arterial Stents Comprehensive Study by Type (Coronary Stents, Peripheral Stents), Application (Coronary Artery, Carotid Artery, Carotid Artery, Femoral & Popliteal Artery), End Users (Hospitals, Diagnostic Centers, Surgical Centers, Others), Sales Channel (Online, Offline), Material (Metal, Polymer, NiTi, Magnesium) Players and Region - Global Market Outlook to 2027

Arterial Stents Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Apr 2022 Edition 232 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Arterial Stents Market?

Arterial stent is a small tube that is commonly placed during or immediately after angioplasty. It expands inside a coronary artery and prevents the artery from closing up again in a long term. In today’s time, the demand for vascular stents is increasing rapidly with the increasing number of people with heart diseases and other chronic diseases due to changes in lifestyles and lack of exercise. Further, the stents made from a biodegradable polymer are widely used due to their multiple advantages including complete elution of drugs, reduced inflammatory response, and also decreases the risk of late complications like stent strut uncovering, mal-apposition, and endothelial.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledCardinal Health (United States), Medtronic (Ireland), Abbott Laboratories (United States), Cook Group (United States), Boston Scientific (United States), Gore Medical (United States), Bard LifeStar (United States), Cordis Corporation (United States), MeKo (Germany) and Integer Holdings Corporation (United States)
CAGR%


The market study is being classified by Type (Coronary Stents and Peripheral Stents), by Application (Coronary Artery, Carotid Artery, Carotid Artery and Femoral & Popliteal Artery) and major geographies with country level break-up.

Cardinal Health (United States), Medtronic (Ireland), Abbott Laboratories (United States), Cook Group (United States), Boston Scientific (United States), Gore Medical (United States), Bard LifeStar (United States), Cordis Corporation (United States), MeKo (Germany) and Integer Holdings Corporation (United States) are some of the key players profiled in the study.

The key manufacturers are targeting the innovations of the products with better quality, and better technical characteristics, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking about mergers and acquisitions in order to maintain their presence in the market Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Arterial Stents market throughout the forecasted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Arterial Stents market by Type, Application and Region.

On the basis of geography, the market of Arterial Stents has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Number of Patients with Coronary Artery Disease Across the Globe Due to Change in Eating Habits and Lack of Exercise
  • Surging Demand for Technologically Advanced Solutions to Perform Less Invasive and Less Painful Surgical Procedure

Market Trend
  • Wide Application of Polymer in Cardiology and Increased Focus on the Development of Arterial Stents from Biodegradable Polymer and Modification of Oxide Layer on Niti Stent Corrosion Resistance

Restraints
  • High Cost Associated with Angioplasty and Arterial Stents is the Biggest Restraint for the Market
  • Lack of Awareness About the Arterial Stents in the Rural Areas and Inadequate Funding May Limit the Adoption

Opportunities
  • Growing Popularity of NiTi Stents Due to Its High Sensitivity of Corrosion and Fatigue Resistance
  • Increasing Geriatric Population with Chronic Diseases Across the Globe Especially in North America Will Boost Market

Challenges
  • Risk of Re-Narrowing Of the Artery in Bare-Metal Stents Can Hamper the Growth





Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Arterial Stents Manufacturers, Suppliers and Distributors of Arterial Stents, Venture Capitalists and Private Equity Firms, Government Bodies and Research Organizations, End-Users and Others

Frequently Asked Questions (FAQ):

1. Which factors would majorly drive the Arterial Stents Market?
"Increasing Number of Patients with Coronary Artery Disease Across the Globe Due to Change in Eating Habits and Lack of Exercise " is seen as one of major growth factors of Arterial Stents Market in years to come.

2. Can we have customized study for Arterial Stents Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. Which region will lead the Global Arterial Stents Market?
United States will lead Arterial Stents Market in coming years.
Report Objectives / Segmentation Covered
By Type
  • Coronary Stents
  • Peripheral Stents
By Application
  • Coronary Artery
  • Carotid Artery
  • Carotid Artery
  • Femoral & Popliteal Artery
By End Users
  • Hospitals
  • Diagnostic Centers
  • Surgical Centers
  • Others

By Sales Channel
  • Online
  • Offline

By Material
  • Metal
  • Polymer
  • NiTi
  • Magnesium

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Patients with Coronary Artery Disease Across the Globe Due to Change in Eating Habits and Lack of Exercise
      • 3.2.2. Surging Demand for Technologically Advanced Solutions to Perform Less Invasive and Less Painful Surgical Procedure
    • 3.3. Market Challenges
      • 3.3.1. Risk of Re-Narrowing Of the Artery in Bare-Metal Stents Can Hamper the Growth
    • 3.4. Market Trends
      • 3.4.1. Wide Application of Polymer in Cardiology and Increased Focus on the Development of Arterial Stents from Biodegradable Polymer and Modification of Oxide Layer on Niti Stent Corrosion Resistance
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Arterial Stents, by Type, Application, End Users, Sales Channel, Material and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Arterial Stents (Value)
      • 5.2.1. Global Arterial Stents by: Type (Value)
        • 5.2.1.1. Coronary Stents
        • 5.2.1.2. Peripheral Stents
      • 5.2.2. Global Arterial Stents by: Application (Value)
        • 5.2.2.1. Coronary Artery
        • 5.2.2.2. Carotid Artery
        • 5.2.2.3. Carotid Artery
        • 5.2.2.4. Femoral & Popliteal Artery
      • 5.2.3. Global Arterial Stents by: End Users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Diagnostic Centers
        • 5.2.3.3. Surgical Centers
        • 5.2.3.4. Others
      • 5.2.4. Global Arterial Stents by: Sales Channel (Value)
        • 5.2.4.1. Online
        • 5.2.4.2. Offline
      • 5.2.5. Global Arterial Stents by: Material (Value)
        • 5.2.5.1. Metal
        • 5.2.5.2. Polymer
        • 5.2.5.3. NiTi
        • 5.2.5.4. Magnesium
      • 5.2.6. Global Arterial Stents Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Arterial Stents (Price)
      • 5.3.1. Global Arterial Stents by: Type (Price)
  • 6. Arterial Stents: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cardinal Health (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cook Group (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Boston Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Gore Medical (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bard LifeStar (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cordis Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. MeKo (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Integer Holdings Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Arterial Stents Sale, by Type, Application, End Users, Sales Channel, Material and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Arterial Stents (Value)
      • 7.2.1. Global Arterial Stents by: Type (Value)
        • 7.2.1.1. Coronary Stents
        • 7.2.1.2. Peripheral Stents
      • 7.2.2. Global Arterial Stents by: Application (Value)
        • 7.2.2.1. Coronary Artery
        • 7.2.2.2. Carotid Artery
        • 7.2.2.3. Carotid Artery
        • 7.2.2.4. Femoral & Popliteal Artery
      • 7.2.3. Global Arterial Stents by: End Users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Diagnostic Centers
        • 7.2.3.3. Surgical Centers
        • 7.2.3.4. Others
      • 7.2.4. Global Arterial Stents by: Sales Channel (Value)
        • 7.2.4.1. Online
        • 7.2.4.2. Offline
      • 7.2.5. Global Arterial Stents by: Material (Value)
        • 7.2.5.1. Metal
        • 7.2.5.2. Polymer
        • 7.2.5.3. NiTi
        • 7.2.5.4. Magnesium
      • 7.2.6. Global Arterial Stents Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Arterial Stents (Price)
      • 7.3.1. Global Arterial Stents by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Arterial Stents: by Type(USD Million)
  • Table 2. Arterial Stents Coronary Stents , by Region USD Million (2016-2021)
  • Table 3. Arterial Stents Peripheral Stents , by Region USD Million (2016-2021)
  • Table 4. Arterial Stents: by Application(USD Million)
  • Table 5. Arterial Stents Coronary Artery , by Region USD Million (2016-2021)
  • Table 6. Arterial Stents Carotid Artery , by Region USD Million (2016-2021)
  • Table 7. Arterial Stents Carotid Artery , by Region USD Million (2016-2021)
  • Table 8. Arterial Stents Femoral & Popliteal Artery , by Region USD Million (2016-2021)
  • Table 9. Arterial Stents: by End Users(USD Million)
  • Table 10. Arterial Stents Hospitals , by Region USD Million (2016-2021)
  • Table 11. Arterial Stents Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 12. Arterial Stents Surgical Centers , by Region USD Million (2016-2021)
  • Table 13. Arterial Stents Others , by Region USD Million (2016-2021)
  • Table 14. Arterial Stents: by Sales Channel(USD Million)
  • Table 15. Arterial Stents Online , by Region USD Million (2016-2021)
  • Table 16. Arterial Stents Offline , by Region USD Million (2016-2021)
  • Table 17. Arterial Stents: by Material(USD Million)
  • Table 18. Arterial Stents Metal , by Region USD Million (2016-2021)
  • Table 19. Arterial Stents Polymer , by Region USD Million (2016-2021)
  • Table 20. Arterial Stents NiTi , by Region USD Million (2016-2021)
  • Table 21. Arterial Stents Magnesium , by Region USD Million (2016-2021)
  • Table 22. South America Arterial Stents, by Country USD Million (2016-2021)
  • Table 23. South America Arterial Stents, by Type USD Million (2016-2021)
  • Table 24. South America Arterial Stents, by Application USD Million (2016-2021)
  • Table 25. South America Arterial Stents, by End Users USD Million (2016-2021)
  • Table 26. South America Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 27. South America Arterial Stents, by Material USD Million (2016-2021)
  • Table 28. Brazil Arterial Stents, by Type USD Million (2016-2021)
  • Table 29. Brazil Arterial Stents, by Application USD Million (2016-2021)
  • Table 30. Brazil Arterial Stents, by End Users USD Million (2016-2021)
  • Table 31. Brazil Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 32. Brazil Arterial Stents, by Material USD Million (2016-2021)
  • Table 33. Argentina Arterial Stents, by Type USD Million (2016-2021)
  • Table 34. Argentina Arterial Stents, by Application USD Million (2016-2021)
  • Table 35. Argentina Arterial Stents, by End Users USD Million (2016-2021)
  • Table 36. Argentina Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 37. Argentina Arterial Stents, by Material USD Million (2016-2021)
  • Table 38. Rest of South America Arterial Stents, by Type USD Million (2016-2021)
  • Table 39. Rest of South America Arterial Stents, by Application USD Million (2016-2021)
  • Table 40. Rest of South America Arterial Stents, by End Users USD Million (2016-2021)
  • Table 41. Rest of South America Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 42. Rest of South America Arterial Stents, by Material USD Million (2016-2021)
  • Table 43. Asia Pacific Arterial Stents, by Country USD Million (2016-2021)
  • Table 44. Asia Pacific Arterial Stents, by Type USD Million (2016-2021)
  • Table 45. Asia Pacific Arterial Stents, by Application USD Million (2016-2021)
  • Table 46. Asia Pacific Arterial Stents, by End Users USD Million (2016-2021)
  • Table 47. Asia Pacific Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 48. Asia Pacific Arterial Stents, by Material USD Million (2016-2021)
  • Table 49. China Arterial Stents, by Type USD Million (2016-2021)
  • Table 50. China Arterial Stents, by Application USD Million (2016-2021)
  • Table 51. China Arterial Stents, by End Users USD Million (2016-2021)
  • Table 52. China Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 53. China Arterial Stents, by Material USD Million (2016-2021)
  • Table 54. Japan Arterial Stents, by Type USD Million (2016-2021)
  • Table 55. Japan Arterial Stents, by Application USD Million (2016-2021)
  • Table 56. Japan Arterial Stents, by End Users USD Million (2016-2021)
  • Table 57. Japan Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 58. Japan Arterial Stents, by Material USD Million (2016-2021)
  • Table 59. India Arterial Stents, by Type USD Million (2016-2021)
  • Table 60. India Arterial Stents, by Application USD Million (2016-2021)
  • Table 61. India Arterial Stents, by End Users USD Million (2016-2021)
  • Table 62. India Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 63. India Arterial Stents, by Material USD Million (2016-2021)
  • Table 64. South Korea Arterial Stents, by Type USD Million (2016-2021)
  • Table 65. South Korea Arterial Stents, by Application USD Million (2016-2021)
  • Table 66. South Korea Arterial Stents, by End Users USD Million (2016-2021)
  • Table 67. South Korea Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 68. South Korea Arterial Stents, by Material USD Million (2016-2021)
  • Table 69. Taiwan Arterial Stents, by Type USD Million (2016-2021)
  • Table 70. Taiwan Arterial Stents, by Application USD Million (2016-2021)
  • Table 71. Taiwan Arterial Stents, by End Users USD Million (2016-2021)
  • Table 72. Taiwan Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 73. Taiwan Arterial Stents, by Material USD Million (2016-2021)
  • Table 74. Australia Arterial Stents, by Type USD Million (2016-2021)
  • Table 75. Australia Arterial Stents, by Application USD Million (2016-2021)
  • Table 76. Australia Arterial Stents, by End Users USD Million (2016-2021)
  • Table 77. Australia Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 78. Australia Arterial Stents, by Material USD Million (2016-2021)
  • Table 79. Rest of Asia-Pacific Arterial Stents, by Type USD Million (2016-2021)
  • Table 80. Rest of Asia-Pacific Arterial Stents, by Application USD Million (2016-2021)
  • Table 81. Rest of Asia-Pacific Arterial Stents, by End Users USD Million (2016-2021)
  • Table 82. Rest of Asia-Pacific Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 83. Rest of Asia-Pacific Arterial Stents, by Material USD Million (2016-2021)
  • Table 84. Europe Arterial Stents, by Country USD Million (2016-2021)
  • Table 85. Europe Arterial Stents, by Type USD Million (2016-2021)
  • Table 86. Europe Arterial Stents, by Application USD Million (2016-2021)
  • Table 87. Europe Arterial Stents, by End Users USD Million (2016-2021)
  • Table 88. Europe Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 89. Europe Arterial Stents, by Material USD Million (2016-2021)
  • Table 90. Germany Arterial Stents, by Type USD Million (2016-2021)
  • Table 91. Germany Arterial Stents, by Application USD Million (2016-2021)
  • Table 92. Germany Arterial Stents, by End Users USD Million (2016-2021)
  • Table 93. Germany Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 94. Germany Arterial Stents, by Material USD Million (2016-2021)
  • Table 95. France Arterial Stents, by Type USD Million (2016-2021)
  • Table 96. France Arterial Stents, by Application USD Million (2016-2021)
  • Table 97. France Arterial Stents, by End Users USD Million (2016-2021)
  • Table 98. France Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 99. France Arterial Stents, by Material USD Million (2016-2021)
  • Table 100. Italy Arterial Stents, by Type USD Million (2016-2021)
  • Table 101. Italy Arterial Stents, by Application USD Million (2016-2021)
  • Table 102. Italy Arterial Stents, by End Users USD Million (2016-2021)
  • Table 103. Italy Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 104. Italy Arterial Stents, by Material USD Million (2016-2021)
  • Table 105. United Kingdom Arterial Stents, by Type USD Million (2016-2021)
  • Table 106. United Kingdom Arterial Stents, by Application USD Million (2016-2021)
  • Table 107. United Kingdom Arterial Stents, by End Users USD Million (2016-2021)
  • Table 108. United Kingdom Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 109. United Kingdom Arterial Stents, by Material USD Million (2016-2021)
  • Table 110. Netherlands Arterial Stents, by Type USD Million (2016-2021)
  • Table 111. Netherlands Arterial Stents, by Application USD Million (2016-2021)
  • Table 112. Netherlands Arterial Stents, by End Users USD Million (2016-2021)
  • Table 113. Netherlands Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 114. Netherlands Arterial Stents, by Material USD Million (2016-2021)
  • Table 115. Rest of Europe Arterial Stents, by Type USD Million (2016-2021)
  • Table 116. Rest of Europe Arterial Stents, by Application USD Million (2016-2021)
  • Table 117. Rest of Europe Arterial Stents, by End Users USD Million (2016-2021)
  • Table 118. Rest of Europe Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 119. Rest of Europe Arterial Stents, by Material USD Million (2016-2021)
  • Table 120. MEA Arterial Stents, by Country USD Million (2016-2021)
  • Table 121. MEA Arterial Stents, by Type USD Million (2016-2021)
  • Table 122. MEA Arterial Stents, by Application USD Million (2016-2021)
  • Table 123. MEA Arterial Stents, by End Users USD Million (2016-2021)
  • Table 124. MEA Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 125. MEA Arterial Stents, by Material USD Million (2016-2021)
  • Table 126. Middle East Arterial Stents, by Type USD Million (2016-2021)
  • Table 127. Middle East Arterial Stents, by Application USD Million (2016-2021)
  • Table 128. Middle East Arterial Stents, by End Users USD Million (2016-2021)
  • Table 129. Middle East Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 130. Middle East Arterial Stents, by Material USD Million (2016-2021)
  • Table 131. Africa Arterial Stents, by Type USD Million (2016-2021)
  • Table 132. Africa Arterial Stents, by Application USD Million (2016-2021)
  • Table 133. Africa Arterial Stents, by End Users USD Million (2016-2021)
  • Table 134. Africa Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 135. Africa Arterial Stents, by Material USD Million (2016-2021)
  • Table 136. North America Arterial Stents, by Country USD Million (2016-2021)
  • Table 137. North America Arterial Stents, by Type USD Million (2016-2021)
  • Table 138. North America Arterial Stents, by Application USD Million (2016-2021)
  • Table 139. North America Arterial Stents, by End Users USD Million (2016-2021)
  • Table 140. North America Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 141. North America Arterial Stents, by Material USD Million (2016-2021)
  • Table 142. United States Arterial Stents, by Type USD Million (2016-2021)
  • Table 143. United States Arterial Stents, by Application USD Million (2016-2021)
  • Table 144. United States Arterial Stents, by End Users USD Million (2016-2021)
  • Table 145. United States Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 146. United States Arterial Stents, by Material USD Million (2016-2021)
  • Table 147. Canada Arterial Stents, by Type USD Million (2016-2021)
  • Table 148. Canada Arterial Stents, by Application USD Million (2016-2021)
  • Table 149. Canada Arterial Stents, by End Users USD Million (2016-2021)
  • Table 150. Canada Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 151. Canada Arterial Stents, by Material USD Million (2016-2021)
  • Table 152. Mexico Arterial Stents, by Type USD Million (2016-2021)
  • Table 153. Mexico Arterial Stents, by Application USD Million (2016-2021)
  • Table 154. Mexico Arterial Stents, by End Users USD Million (2016-2021)
  • Table 155. Mexico Arterial Stents, by Sales Channel USD Million (2016-2021)
  • Table 156. Mexico Arterial Stents, by Material USD Million (2016-2021)
  • Table 157. Arterial Stents: by Type(USD/Units)
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Arterial Stents: by Type(USD Million)
  • Table 169. Arterial Stents Coronary Stents , by Region USD Million (2022-2027)
  • Table 170. Arterial Stents Peripheral Stents , by Region USD Million (2022-2027)
  • Table 171. Arterial Stents: by Application(USD Million)
  • Table 172. Arterial Stents Coronary Artery , by Region USD Million (2022-2027)
  • Table 173. Arterial Stents Carotid Artery , by Region USD Million (2022-2027)
  • Table 174. Arterial Stents Carotid Artery , by Region USD Million (2022-2027)
  • Table 175. Arterial Stents Femoral & Popliteal Artery , by Region USD Million (2022-2027)
  • Table 176. Arterial Stents: by End Users(USD Million)
  • Table 177. Arterial Stents Hospitals , by Region USD Million (2022-2027)
  • Table 178. Arterial Stents Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 179. Arterial Stents Surgical Centers , by Region USD Million (2022-2027)
  • Table 180. Arterial Stents Others , by Region USD Million (2022-2027)
  • Table 181. Arterial Stents: by Sales Channel(USD Million)
  • Table 182. Arterial Stents Online , by Region USD Million (2022-2027)
  • Table 183. Arterial Stents Offline , by Region USD Million (2022-2027)
  • Table 184. Arterial Stents: by Material(USD Million)
  • Table 185. Arterial Stents Metal , by Region USD Million (2022-2027)
  • Table 186. Arterial Stents Polymer , by Region USD Million (2022-2027)
  • Table 187. Arterial Stents NiTi , by Region USD Million (2022-2027)
  • Table 188. Arterial Stents Magnesium , by Region USD Million (2022-2027)
  • Table 189. South America Arterial Stents, by Country USD Million (2022-2027)
  • Table 190. South America Arterial Stents, by Type USD Million (2022-2027)
  • Table 191. South America Arterial Stents, by Application USD Million (2022-2027)
  • Table 192. South America Arterial Stents, by End Users USD Million (2022-2027)
  • Table 193. South America Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 194. South America Arterial Stents, by Material USD Million (2022-2027)
  • Table 195. Brazil Arterial Stents, by Type USD Million (2022-2027)
  • Table 196. Brazil Arterial Stents, by Application USD Million (2022-2027)
  • Table 197. Brazil Arterial Stents, by End Users USD Million (2022-2027)
  • Table 198. Brazil Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 199. Brazil Arterial Stents, by Material USD Million (2022-2027)
  • Table 200. Argentina Arterial Stents, by Type USD Million (2022-2027)
  • Table 201. Argentina Arterial Stents, by Application USD Million (2022-2027)
  • Table 202. Argentina Arterial Stents, by End Users USD Million (2022-2027)
  • Table 203. Argentina Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 204. Argentina Arterial Stents, by Material USD Million (2022-2027)
  • Table 205. Rest of South America Arterial Stents, by Type USD Million (2022-2027)
  • Table 206. Rest of South America Arterial Stents, by Application USD Million (2022-2027)
  • Table 207. Rest of South America Arterial Stents, by End Users USD Million (2022-2027)
  • Table 208. Rest of South America Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 209. Rest of South America Arterial Stents, by Material USD Million (2022-2027)
  • Table 210. Asia Pacific Arterial Stents, by Country USD Million (2022-2027)
  • Table 211. Asia Pacific Arterial Stents, by Type USD Million (2022-2027)
  • Table 212. Asia Pacific Arterial Stents, by Application USD Million (2022-2027)
  • Table 213. Asia Pacific Arterial Stents, by End Users USD Million (2022-2027)
  • Table 214. Asia Pacific Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 215. Asia Pacific Arterial Stents, by Material USD Million (2022-2027)
  • Table 216. China Arterial Stents, by Type USD Million (2022-2027)
  • Table 217. China Arterial Stents, by Application USD Million (2022-2027)
  • Table 218. China Arterial Stents, by End Users USD Million (2022-2027)
  • Table 219. China Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 220. China Arterial Stents, by Material USD Million (2022-2027)
  • Table 221. Japan Arterial Stents, by Type USD Million (2022-2027)
  • Table 222. Japan Arterial Stents, by Application USD Million (2022-2027)
  • Table 223. Japan Arterial Stents, by End Users USD Million (2022-2027)
  • Table 224. Japan Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 225. Japan Arterial Stents, by Material USD Million (2022-2027)
  • Table 226. India Arterial Stents, by Type USD Million (2022-2027)
  • Table 227. India Arterial Stents, by Application USD Million (2022-2027)
  • Table 228. India Arterial Stents, by End Users USD Million (2022-2027)
  • Table 229. India Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 230. India Arterial Stents, by Material USD Million (2022-2027)
  • Table 231. South Korea Arterial Stents, by Type USD Million (2022-2027)
  • Table 232. South Korea Arterial Stents, by Application USD Million (2022-2027)
  • Table 233. South Korea Arterial Stents, by End Users USD Million (2022-2027)
  • Table 234. South Korea Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 235. South Korea Arterial Stents, by Material USD Million (2022-2027)
  • Table 236. Taiwan Arterial Stents, by Type USD Million (2022-2027)
  • Table 237. Taiwan Arterial Stents, by Application USD Million (2022-2027)
  • Table 238. Taiwan Arterial Stents, by End Users USD Million (2022-2027)
  • Table 239. Taiwan Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 240. Taiwan Arterial Stents, by Material USD Million (2022-2027)
  • Table 241. Australia Arterial Stents, by Type USD Million (2022-2027)
  • Table 242. Australia Arterial Stents, by Application USD Million (2022-2027)
  • Table 243. Australia Arterial Stents, by End Users USD Million (2022-2027)
  • Table 244. Australia Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 245. Australia Arterial Stents, by Material USD Million (2022-2027)
  • Table 246. Rest of Asia-Pacific Arterial Stents, by Type USD Million (2022-2027)
  • Table 247. Rest of Asia-Pacific Arterial Stents, by Application USD Million (2022-2027)
  • Table 248. Rest of Asia-Pacific Arterial Stents, by End Users USD Million (2022-2027)
  • Table 249. Rest of Asia-Pacific Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 250. Rest of Asia-Pacific Arterial Stents, by Material USD Million (2022-2027)
  • Table 251. Europe Arterial Stents, by Country USD Million (2022-2027)
  • Table 252. Europe Arterial Stents, by Type USD Million (2022-2027)
  • Table 253. Europe Arterial Stents, by Application USD Million (2022-2027)
  • Table 254. Europe Arterial Stents, by End Users USD Million (2022-2027)
  • Table 255. Europe Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 256. Europe Arterial Stents, by Material USD Million (2022-2027)
  • Table 257. Germany Arterial Stents, by Type USD Million (2022-2027)
  • Table 258. Germany Arterial Stents, by Application USD Million (2022-2027)
  • Table 259. Germany Arterial Stents, by End Users USD Million (2022-2027)
  • Table 260. Germany Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 261. Germany Arterial Stents, by Material USD Million (2022-2027)
  • Table 262. France Arterial Stents, by Type USD Million (2022-2027)
  • Table 263. France Arterial Stents, by Application USD Million (2022-2027)
  • Table 264. France Arterial Stents, by End Users USD Million (2022-2027)
  • Table 265. France Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 266. France Arterial Stents, by Material USD Million (2022-2027)
  • Table 267. Italy Arterial Stents, by Type USD Million (2022-2027)
  • Table 268. Italy Arterial Stents, by Application USD Million (2022-2027)
  • Table 269. Italy Arterial Stents, by End Users USD Million (2022-2027)
  • Table 270. Italy Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 271. Italy Arterial Stents, by Material USD Million (2022-2027)
  • Table 272. United Kingdom Arterial Stents, by Type USD Million (2022-2027)
  • Table 273. United Kingdom Arterial Stents, by Application USD Million (2022-2027)
  • Table 274. United Kingdom Arterial Stents, by End Users USD Million (2022-2027)
  • Table 275. United Kingdom Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 276. United Kingdom Arterial Stents, by Material USD Million (2022-2027)
  • Table 277. Netherlands Arterial Stents, by Type USD Million (2022-2027)
  • Table 278. Netherlands Arterial Stents, by Application USD Million (2022-2027)
  • Table 279. Netherlands Arterial Stents, by End Users USD Million (2022-2027)
  • Table 280. Netherlands Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 281. Netherlands Arterial Stents, by Material USD Million (2022-2027)
  • Table 282. Rest of Europe Arterial Stents, by Type USD Million (2022-2027)
  • Table 283. Rest of Europe Arterial Stents, by Application USD Million (2022-2027)
  • Table 284. Rest of Europe Arterial Stents, by End Users USD Million (2022-2027)
  • Table 285. Rest of Europe Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 286. Rest of Europe Arterial Stents, by Material USD Million (2022-2027)
  • Table 287. MEA Arterial Stents, by Country USD Million (2022-2027)
  • Table 288. MEA Arterial Stents, by Type USD Million (2022-2027)
  • Table 289. MEA Arterial Stents, by Application USD Million (2022-2027)
  • Table 290. MEA Arterial Stents, by End Users USD Million (2022-2027)
  • Table 291. MEA Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 292. MEA Arterial Stents, by Material USD Million (2022-2027)
  • Table 293. Middle East Arterial Stents, by Type USD Million (2022-2027)
  • Table 294. Middle East Arterial Stents, by Application USD Million (2022-2027)
  • Table 295. Middle East Arterial Stents, by End Users USD Million (2022-2027)
  • Table 296. Middle East Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 297. Middle East Arterial Stents, by Material USD Million (2022-2027)
  • Table 298. Africa Arterial Stents, by Type USD Million (2022-2027)
  • Table 299. Africa Arterial Stents, by Application USD Million (2022-2027)
  • Table 300. Africa Arterial Stents, by End Users USD Million (2022-2027)
  • Table 301. Africa Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 302. Africa Arterial Stents, by Material USD Million (2022-2027)
  • Table 303. North America Arterial Stents, by Country USD Million (2022-2027)
  • Table 304. North America Arterial Stents, by Type USD Million (2022-2027)
  • Table 305. North America Arterial Stents, by Application USD Million (2022-2027)
  • Table 306. North America Arterial Stents, by End Users USD Million (2022-2027)
  • Table 307. North America Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 308. North America Arterial Stents, by Material USD Million (2022-2027)
  • Table 309. United States Arterial Stents, by Type USD Million (2022-2027)
  • Table 310. United States Arterial Stents, by Application USD Million (2022-2027)
  • Table 311. United States Arterial Stents, by End Users USD Million (2022-2027)
  • Table 312. United States Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 313. United States Arterial Stents, by Material USD Million (2022-2027)
  • Table 314. Canada Arterial Stents, by Type USD Million (2022-2027)
  • Table 315. Canada Arterial Stents, by Application USD Million (2022-2027)
  • Table 316. Canada Arterial Stents, by End Users USD Million (2022-2027)
  • Table 317. Canada Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 318. Canada Arterial Stents, by Material USD Million (2022-2027)
  • Table 319. Mexico Arterial Stents, by Type USD Million (2022-2027)
  • Table 320. Mexico Arterial Stents, by Application USD Million (2022-2027)
  • Table 321. Mexico Arterial Stents, by End Users USD Million (2022-2027)
  • Table 322. Mexico Arterial Stents, by Sales Channel USD Million (2022-2027)
  • Table 323. Mexico Arterial Stents, by Material USD Million (2022-2027)
  • Table 324. Arterial Stents: by Type(USD/Units)
  • Table 325. Research Programs/Design for This Report
  • Table 326. Key Data Information from Secondary Sources
  • Table 327. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Arterial Stents: by Type USD Million (2016-2021)
  • Figure 5. Global Arterial Stents: by Application USD Million (2016-2021)
  • Figure 6. Global Arterial Stents: by End Users USD Million (2016-2021)
  • Figure 7. Global Arterial Stents: by Sales Channel USD Million (2016-2021)
  • Figure 8. Global Arterial Stents: by Material USD Million (2016-2021)
  • Figure 9. South America Arterial Stents Share (%), by Country
  • Figure 10. Asia Pacific Arterial Stents Share (%), by Country
  • Figure 11. Europe Arterial Stents Share (%), by Country
  • Figure 12. MEA Arterial Stents Share (%), by Country
  • Figure 13. North America Arterial Stents Share (%), by Country
  • Figure 14. Global Arterial Stents: by Type USD/Units (2016-2021)
  • Figure 15. Global Arterial Stents share by Players 2021 (%)
  • Figure 16. Global Arterial Stents share by Players (Top 3) 2021(%)
  • Figure 17. Global Arterial Stents share by Players (Top 5) 2021(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Cardinal Health (United States) Revenue, Net Income and Gross profit
  • Figure 20. Cardinal Health (United States) Revenue: by Geography 2021
  • Figure 21. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 22. Medtronic (Ireland) Revenue: by Geography 2021
  • Figure 23. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 25. Cook Group (United States) Revenue, Net Income and Gross profit
  • Figure 26. Cook Group (United States) Revenue: by Geography 2021
  • Figure 27. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. Boston Scientific (United States) Revenue: by Geography 2021
  • Figure 29. Gore Medical (United States) Revenue, Net Income and Gross profit
  • Figure 30. Gore Medical (United States) Revenue: by Geography 2021
  • Figure 31. Bard LifeStar (United States) Revenue, Net Income and Gross profit
  • Figure 32. Bard LifeStar (United States) Revenue: by Geography 2021
  • Figure 33. Cordis Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Cordis Corporation (United States) Revenue: by Geography 2021
  • Figure 35. MeKo (Germany) Revenue, Net Income and Gross profit
  • Figure 36. MeKo (Germany) Revenue: by Geography 2021
  • Figure 37. Integer Holdings Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Integer Holdings Corporation (United States) Revenue: by Geography 2021
  • Figure 39. Global Arterial Stents: by Type USD Million (2022-2027)
  • Figure 40. Global Arterial Stents: by Application USD Million (2022-2027)
  • Figure 41. Global Arterial Stents: by End Users USD Million (2022-2027)
  • Figure 42. Global Arterial Stents: by Sales Channel USD Million (2022-2027)
  • Figure 43. Global Arterial Stents: by Material USD Million (2022-2027)
  • Figure 44. South America Arterial Stents Share (%), by Country
  • Figure 45. Asia Pacific Arterial Stents Share (%), by Country
  • Figure 46. Europe Arterial Stents Share (%), by Country
  • Figure 47. MEA Arterial Stents Share (%), by Country
  • Figure 48. North America Arterial Stents Share (%), by Country
  • Figure 49. Global Arterial Stents: by Type USD/Units (2022-2027)
Some of the key companies/manufacturers profiled in the report
  • Cardinal Health (United States)
  • Medtronic (Ireland)
  • Abbott Laboratories (United States)
  • Cook Group (United States)
  • Boston Scientific (United States)
  • Gore Medical (United States)
  • Bard LifeStar (United States)
  • Cordis Corporation (United States)
  • MeKo (Germany)
  • Integer Holdings Corporation (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation